The clinical efficacy and effectiveness of the Lu-177 DOTATATE therapy

被引：0
|
作者：
Acar, E. [1 ]
Durak, H. [1 ]
Kaya, G. Capa [1 ]
机构：
[1] Dokuz Eylul Univ, Sch Med, Dept Nucl Med, Izmir, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P797
引用
收藏
页码：S723 / S723
页数：1
相关论文
共 50 条
  • [31] Evaluation of infusion pump delivery system for LUTATHERA® (lutetium Lu-177 dotatate).
    Doherty, Kathryn
    Houston, Tim
    Kowalczyk, Steven
    Gruchot, Michelle
    Dillehay, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [32] Comparative Dosimetric Evaluation on the course of PRRT using non carrier added LU-177 DOTATATE (i.a., i.v), non carrier added LU-177 DOTATOC (i.v.) and carrier added LU-177 DOTATATE (i.v.)
    Paphiti, M.
    McCready, R. V.
    Dimitriadi, E. Z.
    Limouris, G. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S190 - S191
  • [33] A 10-Year Evolution of Patient Dosimetry for Lu-177 Dotatate Peptide Receptor Radionuclide Therapy (PRRT)
    Ross, Erin
    Ram, Lydia
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [34] Performance evaluation of a personalized remote radiation tracking vest for at home monitoring of Lu-177 DOTATATE therapy.
    Miyaoka, Robert
    Pierce, Larry
    Harrison, Robert
    Vesselle, Hubert
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [35] 177LU-DOTATATE THERAPY IN PROGRESSIVE MENINGIOMA
    Muether, M.
    Roll, W.
    Zinnhardt, B.
    Schaefers, M.
    Rahbar, K.
    Brokinkel, B.
    Stummer, W.
    NEURO-ONCOLOGY, 2019, 21 : 39 - 39
  • [36] Clinical Implementation of FDA Approved Radiopharmaceutical Lu-177
    George, S.
    George, J.
    Mishra, V.
    Chuong, M.
    Gutierrez, A.
    MEDICAL PHYSICS, 2019, 46 (06) : E544 - E544
  • [37] COMPARISON OF GA-68 DOTATATE SCANNING AND LU-177 DOTATATE SCANNING IN NET PATIENTS UNDERGOING PRRT
    Bency, R.
    McKay, E.
    Farlow, D.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 22 - 22
  • [38] Effectivity and Toxicity of Salvage PRRT with Lu-177 DOTATATE in patients with progressive, metastasized NET
    Rudisile, Simon
    Gosewisch, Astrid
    Gildehaus, Franz Josef
    Boening, Guido
    Auernhammer, Christoph
    Bartenstein, Peter
    Todica, Andrei
    Ilhan, Harun
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [39] Added Value of SPECT/CT in Post Lu-177 Dotatate Treatment for Neuroendocrine Tumors
    Couch, Paige
    Webb, Chelsea
    Botkin, Crystal
    Frye, Sarah
    Muzaffar, Razi
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [40] 177Lu-DOTATATE therapy in progressive meningioma
    Roll, W.
    Muether, M.
    Zinnhardt, B.
    Stegger, L.
    Schaefers, M.
    Weckesser, M.
    Stummer, W.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S644 - S644
12345